Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 4

Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

Total article views   HTML views PDF downloads Totals
7,224 Dovepress* 7,224+ 1,691 8,915
Totals 7,224 1,691 8,915
*Since 5 December 2008
+Since July 2016

View citations on Google Scholar